Research News for December 21, 2022
advertisement
- Possible new Type 1 diabetes treatment under study by MU researchers
- Diabetes mellitus degenerates cisplatin-induced nephrotoxicity in short hydration method: a propensity score-matching analysis
- Researchers identify insulin-mimicking molecule that could treat diabetes
- Fas Ligand-Modified Scaffolds Protect Stem Cell Derived β-Cells by Modulating Immune Cell Numbers and Polarization
- New-onset type 1 diabetes and SARS-CoV-2 infection
- Fecal microbiota transplantation treatment of autoimmune-mediated type 1 diabetes: A systematic review (Full text HTML, PDF)
- Multiomics signatures of type 1 diabetes with and without albuminuria
- Multi-omic interactions in the gut of children at the onset of islet autoimmunity (Full text HTML, PDF)
- Involvement of trained immunity during autoimmune responses
- Particle-Based Therapies for Antigen Specific Treatment of Type 1 Diabetes
- DMPPred: a tool for identification of antigenic regions responsible for inducing type 1 diabetes mellitus
- Incomplete time-series gene expression in integrative study for islet autoimmunity prediction
- Seasonality of month of birth in patients with autoimmune endocrine diseases: A systematic review
- hUCMSCs carrying exenatide prevent T1DM by improving intestinal microflora composition and islet tissue damage repair (Full text HTML, PDF)
- The genetic diversity of proteasome genes in the T1DM Polish population
- Estimated glucose disposal rate and risk of cardiovascular disease: evidence from the China Health and Retirement Longitudinal Study (Full text HTML, PDF)
- Restoring glutamate receptor signaling in pancreatic alpha cells rescues glucagon responses in type 1 diabetes
- ADAR1-dependent editing regulates human β cell transcriptome diversity during inflammation (Full text HTML, PDF)
